Summary
Pharmada is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €169,021 and a net result of €83,597. Its solvency ranks better than 15% of 6,640 sector peers (NACE 64, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- Pharmada
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Benoemd met of zonder beperking van duur, bestuursorgaan” (deed in Dutch)“Behalve deze die wet of statuten aan algemene vergadering voorbehouden, geheel van bevoegdheden aan enige bestuurder” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 15 June at 20:00
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor